The study design and compliance may affect strength of inferences

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 6, 2012, Pages e9-

  Gallos, Ioannis D ^a   Gupta, Janesh K ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GESTAGEN; LEVONORGESTREL;

ACCURACY; COHORT ANALYSIS; DRUG EFFICACY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HYPOTHESIS; LETTER; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK; STUDY DESIGN; TREATMENT RESPONSE;

EID: 84869509852     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.07.015     Document Type: Letter

References (4)

1. K. Upson, K. Allison, S. Reed Biomarkers of progestin therapy resistance and endometrial hyperplasia progression Am J Obstet Gynecol 207 2012 36.e1 36.e8
2. I.D. Gallos, M. Shehmar, S. Thangaratinam, T.K. Papapostolou, A. Coomarasamy, J.K. Gupta Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis Am J Obstet Gynecol 203 2010 547.e1 547.e10
3. E. Akesson, I.D. Gallos, R. Ganesan, R. Varma, J.K. Gupta Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study Acta Obstet Gynecol Scand 89 2010 393 398
4. J.G. Lijmer, B. Mol, S. Heisterkamp Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282 1999 1061 1066